COMMUNIQUÉS West-GlobeNewswire

Immuron Prices Underwritten Public Offering of ADSs

24/05/2019 - 03:10

MELBOURNE, Australia,, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for [...]

Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardia’s Helix Endocardial Delivery System Improved in Ejection Fraction and NYHA Class

23/05/2019 - 21:23

Late-Breaking Trial Session at EuroPCR Featured Positive Data on Helix System PARIS and SAN CARLOS, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [OTC: BCDA], a leader in the development of comprehensive [...]

Integra LifeSciences to participate in the Jefferies Healthcare Conference and the Raymond James Life Sciences and MedTech Conference in June 2019

23/05/2019 - 22:01

PLAINSBORO, N.J., May 23, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in June: On [...]

Sol-Gel to Present at Upcoming Healthcare Investor Conferences in June

23/05/2019 - 22:05

NESS ZIONA, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

GenMark Diagnostics to Participate in Upcoming Investor Conferences

23/05/2019 - 22:05

CARLSBAD, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to [...]

Genfit : GENFIT lance un programme clinique de combinaisons thérapeutiques dans la NASH

23/05/2019 - 22:05

GENFIT lance un programme clinique de combinaisons thérapeutiques dans la NASH GENFIT a identifié plusieurs composés thérapeutiques présentant une activité synergique avec son composé phare, elafibranor (PPAR alpha/ [...]

Genfit: GENFIT Launches a Combination Therapy Clinical Program in NASH

23/05/2019 - 22:05

GENFIT Launches a Combination Therapy Clinical Program in NASH GENFIT has identified multiple therapeutic compounds synergistic with its lead asset, elafibranor (PPAR alpha/delta), for the treatment of NASH Combined [...]

Equillium to Present at Jefferies 2019 Healthcare Conference

23/05/2019 - 22:07

LA JOLLA, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and [...]

New clinical data demonstrates the versatility of Globus Medical’s ExcelsiusGPS®

23/05/2019 - 22:15

Study reviews 100 cases demonstrating 99% pedicle screw placement success rate AUDUBON, Pa., May 23, 2019 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company today announced the [...]

AIT Therapeutics Participating at the Oppenheimer MedTech Day on May 29

23/05/2019 - 22:15

GARDEN CITY, N.Y. and REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]

Ziopharm Oncology Presentation at the Jefferies 2019 Global Healthcare Conference to be Webcast

23/05/2019 - 22:15

BOSTON, May 23, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP), a clinical stage immuno-oncology company developing next generation cell and gene therapies, today announced that Laurence Cooper, M.D., [...]

The Cooper Companies to Participate in the Raymond James Life Sciences and MedTech Conference

23/05/2019 - 22:15

PLEASANTON, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Raymond James Life Sciences and MedTech Conference in New York, NY, on June 18, 2019. Albert G. White [...]

Neuronetics to Present at the William Blair 39th Annual Growth Stock Conference

23/05/2019 - 22:30

MALVERN, Pa., May 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]

WW Announces Participation in Upcoming Investor Conferences

23/05/2019 - 22:39

NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WW), a global wellness company and the world’s leading commercial weight management program, today announced that Nick Hotchkin, [...]

Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business

23/05/2019 - 22:45

Company will explore strategic alternatives for its immuno-oncology programs Company will align its resources to focus on HEPLISAV-B commercialization Eddie Gray, CEO, to retire BERKELEY, Calif., May 23, 2019 (GLOBE [...]

Immuron Announces Proposed Public Offering of ADSs

23/05/2019 - 22:45

MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the [...]

Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer

23/05/2019 - 23:00

LAVAL, Québec, May 23, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has completed the previously disclosed issuance of 900,000 common shares from [...]

UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And “CBD International Consortium” to Develop Treatment of Opioid Addiction

23/05/2019 - 23:29

MediPharm Labs enters major U.S. led opioid clinical research trial to develop IP and exclusively manufacture CBD gelcaps TORONTO, May 23, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: [...]

Galectin Therapeutics Reports Alternate Price of Common Stock in Rights Offering

23/05/2019 - 23:30

NORCROSS, Ga., May 23, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported the Alternate Price (i.e., the final [...]

COMMUNIQUÉS West-GlobeNewswire

Pages